Loading organizations...

venture capital firm investing in early-stage technology innovations across enterprise and consumer markets, from seed to Series B.
Key people at FountainBridge Capital.
FountainBridge Capital is a China-based venture capital firm that invests in early-stage technology innovations across the enterprise and consumer markets. The firm provides critical growth capital to founders from the seed through Series B funding stages, writing individual checks ranging from $20,000 to $20 million. Operating as either a lead or follow investor, the organization helps bring new technological concepts from conception through their early commercial growth phases. The firm currently manages a diverse portfolio of 17 active companies, including notable investments in MetaX, Matrix Origin, TuringQ, MOMO Dim Sum, and Freebeat. Several of these portfolio companies have secured substantial subsequent capital, with MetaX raising over $300 million and MOMO Dim Sum securing more than $100 million in total external funding. The firm's specific founding year and original founders are not currently publicly disclosed by the organization.
Key people at FountainBridge Capital.
FountainBridge Capital has 1 tracked investment across 1 company. The latest tracked deal is $20.0M Pre-Series A in Epigenic Therapeutics in August 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 8, 2022 | Epigenic Therapeutics | $20.0M Pre-Series A | — | Kingray Capital, Michael Xue, Trinity Innovation Fund |